Share

40th Annual J.P. Morgan HealthCare Conference — Synthetic Biology Panel

— Tycho Peterson, Managing Director, Life Science Tools & Diagnostics, J.P. Morgan
— Ipsita Smolinski, Managing Director, Capitol Street

Abstract: Join the panel to discuss the genetic technology known as synthetic biology. Two industry heavyweights — Ginkgo & Inscripta — will describe genomic engineering & organism technologies. The White House will weigh in on how it evaluates technologies and partnerships to further US science and technology priorities. One key trade association will discuss the impact synthetic biology has on non-health applications, fragrances and other flavors.

Efficient and Rapid Discovery of Novel Temperature Sensitive Alleles with the Onyx ® Digital Genome Engineering Platform
Temperature sensitive (TS) alleles are mutations in essential genes that allow for growth at permissive temperatures and restrict or reduce...
Read More
Accelerating strain development process for CDMO and CRO companies
Manufacturing of proteins, mRNA or small molecules requires comprehensive strain engineering approaches to increase yield, productivity, and robustness of the...
Read More
Improving protein expression in E. coli B‑strains using rapid genome engineering
E. coli B‑strains, such as BL21, and their derivatives are often used for protein expression due to their optimized amino...
Read More
Back To Gallery